KSolves India Ltd.

₹298.55

-18.1 (-5.7%)

KSOLVES Share Price

IT - Software

As on July 16, 2026

SectorInformation Technology

IndustryIT - Software

Basic IndustryComputers - Software & Consulting

Market Cap₹ 712 Cr

P/E Ratio20.63

Dividend Yield1.04 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	300.09	Bearish
10-DMA	293.92	Bullish
20-DMA	290.29	Bullish
50-DMA	286.89	Bullish
100-DMA	292.89	Bullish
200-DMA	295.81	Bullish

Historical Performance

1 Year

-13.4%

3 Years

-43%

5 Years

141.8%

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Operating Expenses	---	---	---	---	---
Other Income	4	3	6	13	2
Operating Profit	485	469	335	214	124
Interest	4	1	---	---	---
Depreciation	22	9	5	5	4
Profit Before Tax	458	459	329	209	120
Consolidated Net Profit	343	342	247	159	89
Adjusted EPS	14	14	10	7	4

Compounded Sales Growth

10 Years:68.5

5 Years:68.5

3 Years:23.9

TTM:4.8

Compounded Profit Growth

10 Years:119.2

5 Years:119.2

3 Years:16.6

TTM:0.1

Stock Price CAGR

10 Years:N/A

5 Years:19.3

3 Years:-18.9

TTM:-20.2

Return on Equity

10 Years:N/A

5 Years:3.8

3 Years:10.4

last year:14.5

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	119	119	119	119	15
Total Reserves	89	120	105	48	119
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	71	15	9	4	2
Other Current Liabilities	60	16	14	6	3
Short Term Borrowings	90	---	---	---	---
Total Liabilities	554	390	336	234	171
Capital Work in Progress	---	---	---	---	---
Long Term Loans & Advances	13	5	4	2	4
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	126	113	78	55	35
Total Current Assets	467	361	320	222	155
Total Assets	554	390	336	234	171
Adjusted Book Value	9	10	19	14	11

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a moderate PE of 20.63, suggesting fair valuation relative to earnings.
Over the last three years, the stock delivered a weak 3-year price CAGR of -18.9%, indicating poor shareholder returns.
The stock carries a high beta of 1.3, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹485 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹1374 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 798155.3

No. of Shares: 2673 (Approx)

Performance:-20.2%

-201844.7

NIFTY Performance: -4.1%

1 day Top Gainers

Symbol	Change%
MRPL	173.33(10%)
CHENNPETRO	1240.8(7%)
ABB	7667.5(6%)
DIXON	14507(6%)
HSCL	722.35(6%)

1 Day Top Losers

Symbol	Change%
ICICIGI	1623.8(-11%)
SIGNATURE	793.15(-6%)
ITCHOTELS	174.12(-5%)
NUVOCO	357.95(-5%)
HDFCAMC	2602.2(-5%)
GODIGIT	284.9(-5%)
AEGISVOPAK	269.26(-5%)
JBCHEPHARM	2408.9(-4%)